HOME >> BIOLOGY >> NEWS
Toward more effective paleolgenetic analysis

DNA preserved in bones undergoing fossilization deteriorates up to 50 times faster when stored in a museum than when the bones are buried in the ground. This has just been shown by a paleogenetics team led by Eva-Maria Geigl (Institut Jacques Mono / CNRS Paris). This study, which was published in the Proceedings of the US National Academy of Sciences 8 January 2007, shows that in order to improve the quality of paleogenetic analyses, archeological and paleontological remains should be treated like biological samples both during and after excavation. The findings show the need for a new methodology for the excavation, treatment and preservation of fossils. They also open up new prospects for paleogenetic research into freshly excavated fossils.

In paleogenetic research, it is essential to have well-preserved archeological material in order to obtain reliable results. At present, such research is only too rarely the result of close collaboration between the various disciplines involved: molecular biologists, archeologists, paleontologists and curators. Moreover, biologists mostly carry out such studies on samples stored in collections or in museums. However, there was no reason to suppose that the treatment carried out by fieldworkers (archeologists, paleontologists and curators), as well as storage conditions, were compatible with a paleogenetic approach. In fact, such analyses were often subject to a high failure rate, due partly to a lack of any ancient DNA detected by PCR , or to contamination by modern DNA.

An extensive study of around 250 fossil bones from 600 to 50 000 year old herbivores was carried out thanks to international cooperation between the Institut Jacques Monod at CNRS, the Museum of Natural Sciences in Madrid and a number of European, Turkish and Japanese paleontologists and archeologists. The work showed that mitochondrial DNA from freshly excavated, untreated fossil bones was amplified with a success rate of 46%. How
'"/>

Contact: Monica McCarthy
monica.mccarthy@cnrs-dir.fr
33-144-965-191
CNRS
17-Jan-2007


Page: 1 2 3

Related biology news :

1. Toward improved forms of a time-tested cholesterol-fighter
2. Dengue and other hemorrhagic fevers: Towards a first potential treatment
3. Towards predicting late-stage radiation toxicity
4. Toward a less expensive, more convenient treatment of Gauchers disease
5. Towards the mechanism of cell respiration
6. Towards a unified model of transcription termination
7. Towards a cheap and easy way to monitor HIV/AIDS
8. Towards targeted lung cancer treatment
9. Toward a better understanding of taste and smell impairments
10. Smokeless tobacco more effective than cigarettes for delivering dangerous carcinogens into the body
11. Developing a more effective vaccine for tuberculosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/7/2017)... Arizona (PRWEB) , ... October ... ... 15 years’ experience providing advanced instruments and applications consulting for microscopy and ... in-house expertise in application consulting, Nanoscience Analytical offers a broad range of ...
Breaking Biology Technology:
Cached News: